Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

United Pharm (033270)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
22,500 -250    -1.10%
02:48:55 - Closed. Currency in KRW ( Disclaimer )
Type:  Equity
Market:  South Korea
ISIN:  KR7033270000 
  • Volume: 17,000
  • Bid/Ask: 22,500 / 22,550
  • Day's Range: 22,350 - 22,700
United Pharm 22,500 -250 -1.10%

033270 Balance Sheet

 
Featured here, the Balance Sheet for United Pharm, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Current Assets 218709.23 204357.48 199662.87 191823.38
Cash and Short Term Investments 129206.78 123202.42 112948.97 103582.7
Cash 14.23 20.26 15.86 13.35
Cash & Equivalents 47616.76 60808.49 50604.91 43564.09
Short Term Investments 81575.79 62373.66 62328.21 60005.25
Total Receivables, Net 46853.99 36993.3 42925.67 43696.34
Accounts Receivables - Trade, Net 45246.21 35904.09 41857.02 42757.05
Total Inventory 42332.97 42433.83 43285 43832.61
Prepaid Expenses 315.49 1727.94 503.22 711.73
Other Current Assets, Total - - - -
Total Assets 397481.8 380032.75 374362.77 365730.3
Property/Plant/Equipment, Total - Net 123259.03 120804.26 120053.25 118859.44
Property/Plant/Equipment, Total - Gross - 158569.14 - -
Accumulated Depreciation, Total - -71179.05 - -
Goodwill, Net - - - -
Intangibles, Net 7204.44 7268.16 7225.7 7952.62
Long Term Investments 43242.69 43570.93 43398.56 43121.42
Note Receivable - Long Term 3627.1 3182.8 3173.29 3149.46
Other Long Term Assets, Total 1439.31 849.12 849.12 823.99
Other Assets, Total - - - -
Total Current Liabilities 73355.51 60854.57 55468.76 58930.04
Accounts Payable 8248.99 6358.97 6324.04 7582.51
Payable/Accrued -0 - - -
Accrued Expenses 17522.95 17277.47 15576.61 13331.6
Notes Payable/Short Term Debt 16180.11 16000 16114.15 21518.01
Current Port. of LT Debt/Capital Leases 5292.3 4020.41 2711.76 1429.59
Other Current liabilities, Total 26111.16 17197.72 14742.2 15068.32
Total Liabilities 90207.17 79323.82 75827.35 78110.3
Total Long Term Debt 11612.52 12970.73 14309.47 12829.1
Long Term Debt 10600 11900 13200 11700
Capital Lease Obligations 1012.52 1070.73 1109.47 1129.1
Deferred Income Tax - 186.59 566.64 776.87
Minority Interest - - - -
Other Liabilities, Total 5239.15 5311.93 5482.47 5574.29
Total Equity 307274.63 300708.93 298535.43 287620
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 8122.41 8122.41 8122.41 8122.41
Additional Paid-In Capital 18730.02 18730.02 18730.02 18730.02
Retained Earnings (Accumulated Deficit) 299275.71 293301.32 291217.77 280414.29
Treasury Stock - Common -22164.25 -22164.25 -22164.25 -22164.25
ESOP Debt Guarantee 804.07 718.81 631.7 544.57
Unrealized Gain (Loss) 1968.55 1962.04 1959.26 1939.13
Other Equity, Total 538.12 38.59 38.52 33.84
Total Liabilities & Shareholders' Equity 397481.8 380032.75 374362.77 365730.3
Total Common Shares Outstanding 14.84 14.84 14.84 14.84
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

033270 Comments

Write your thoughts about United Pharm
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email